CDC does hold patents and license them: the plan reports 87 patents filed and 60 issued in FY2011, and $1,127,457 in royalties collected by CDC's Technology Transfer Office (plus $339,024 via the Office of Infectious Diseases). 'Vaccine candidates' are expressly part of CDC's IP portfolio. So 'CDC owns patents on vaccines' is supported in kind, though the documented royalty scale is modest (about $1.5M in FY2011), not a major revenue stream.
Diagnostic products, unique biologic reagents, vaccine candidates, and occupational safety, health, and environmental tools are the major components of CDC's intellectual property portfolio.
CDC does hold patents and license them: the plan reports 87 patents filed and 60 issued in FY2011, and $1,127,457 in royalties collected by CDC's Technology Transfer Office (plus $339,024 via the Office of Infectious Diseases). 'Vaccine candidates' are expressly part of CDC's IP portfolio. So 'CDC owns patents on vaccines' is supported in kind, though the documented royalty scale is modest (about $1.5M in FY2011), not a major revenue stream.